To include your compound in the COVID-19 Resource Center, submit it here.

Baxter pulls in one stem cell licensee

Baxter pulls in one stem cell licensee

Baxter International's Biotech Group finally has signed one of its rivals in stem cell separation technology to a non-exclusive license

Read the full 277 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE